With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.16874-33-2,Tetrahydrofuran-2-carboxylic acid,as a common compound, the synthetic route is as follows.
EXAMPLE 5; [00113] Preparation of Alfuzosin[00114] To a solution of tetrahydrofuroic acid (5.97 g) in methylene chloride (100 ml) was added thionyl chloride (3.75 ml). After 30 minutes of stirring, N-(4-amino-6,7- dimethoxy-2-quinaaolinyl)-N-methyl-l,3-propanediamine (10.0 g) was added and charged to the reaction mass. To this reaction mass was added triethyl amine, and maintained for about 90 minutes to about 105 minutes. On completion of the reaction as determined by TLC, the reaction mass was filtered to separate the insoluble triethylamine (“TEA”) hydrochloride and the solvent was evaporated at a temperature ranging from about 400C to about 45C under vacuum, to obtain gummy mass. To the gummy mass, isopropyl alcohol (50 ml) was charged and heated to a temperature ranging from about 550C to about 600C and stirred at the same temperature for about 30 to about 35 minutes. The mass was cooled to room temperature. The product was isolated by filtration, washed with isopropyl alcohol (10.0 ml). Wet product was dried at a temperature ranging from about 500C to about 55C to obtained crude alfuzosin (7.8gm). [00115] Purity( by HPLC): Greater than 99.6%, 16874-33-2
The synthetic route of 16874-33-2 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; GLENMARK PHARMACEUTICALS LIMITED; WO2006/90268; (2006); A2;,
Tetrahydrofuran – Wikipedia
Tetrahydrofuran | (CH2)3CH2O – PubChem